Fixing Healthcare Podcast

MTT #104: TrumpRx, rising measles cases & the politics of vaccine science

Mar 4, 2026
They debate a new drug discount program and whether it will actually lower prices. Federal moves to extend telehealth, hospital-at-home pilots and PBM transparency get scrutinized. Rising measles cases, falling trust in vaccine institutions, and new independent vaccine review efforts are discussed. The conversation also touches on mRNA vaccine politics and worrying health trends among younger Americans.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ADVICE

Use TrumpRx Only For Cash Buyers Or GLP-1s

  • Check TrumpRx prices only if you pay cash or need GLP-1 drugs, since insurance can't be used on the site.
  • Most drugs are cheaper through insurance or other services, but GLP-1 weight-loss meds may be an exception.
INSIGHT

CDC Trust Has Collapsed After Guideline Changes

  • Trust in the CDC has fallen to historic lows after major vaccine recommendation changes.
  • Fewer than half of respondents now say they trust the CDC to provide reliable vaccine information, down sharply from pre-pandemic levels.
INSIGHT

Measles Surge Largely Hits Unvaccinated Children

  • Measles cases surged to over 1,100 in early 2026, driven largely by unvaccinated children.
  • About 95% of cases are in inadequately vaccinated people and South Carolina saw sharp local outbreaks prompting increased vaccinations.
Get the Snipd Podcast app to discover more snips from this episode
Get the app